Covalent Medical, LLC – Trademark Portfolio
Entity Type: 16
Covalent Medical, LLC holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 27 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 11 trademarks are registered and 3 are pending. Notable registered marks include FOCUS PI, MACULAPRO, GOT TEARS?, FOCUS RELIEF, and FOCUS SELECT. The owner is based in ALDIE, VA.
24600 MILLSTREAM DRIVE, SUITE 410
ALDIE, VA 20105
Showing of trademarks Trademarks
Trademark Classifications
Covalent Medical, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Covalent Medical, LLC have?
Covalent Medical, LLC has 28 U.S. trademarks filed with the USPTO. Of these, 11 registered, 3 pending, 6 abandoned, 8 cancelled.
What trademark classes does Covalent Medical, LLC file in?
Covalent Medical, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Covalent Medical, LLC's most well-known trademarks?
Covalent Medical, LLC's registered trademark portfolio includes well-known marks such as FOCUS PI, MACULAPRO, GOT TEARS?, FOCUS RELIEF, and FOCUS SELECT. These are among 11 currently registered trademarks in the portfolio.
What is Covalent Medical, LLC's trademark registration success rate?
Covalent Medical, LLC has a 44% trademark registration rate, with 11 out of 25 resolved applications resulting in successful registration. Currently, 3 applications are pending review.